Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

A growing balance of deferred cost of product revenue suggests business fundamentals might be significantly worse than reported.

Amyris Reports Its Largest First-Half Operating Loss Since 2012

Amyris, Inc. (AMRS) CEO John Melo on Q2 2020 Results - Earnings Call Transcript

GW Pharmaceuticals

Village Farms International

These are the marijuana stocks on the nasdaq stocks with the best value, fastest growth, and best performance for August.

Top Marijuana Stocks on the NASDAQ for August 2020

NEW YORK, July 29, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS) relating to.

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS

NEW YORK, July 28, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE AUGUST 14, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Amyris, Inc. ("AMRS" or the "Company") (NASDAQ: AMRS) in connection with the.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.

The synthetic biology pioneer announced a collaboration for its vaccine adjuvant ambitions.

Here's Why Amyris Stock Rose as Much as 12.2% Today

Amyris (NASDAQ: AMRS) shares are trading higher on Monday after the company signed a binding term sheet for a planned COVID-19 RNA vaccine technology program with the Infectious Disease Research Institute.

Why Amyris Is Trading Higher Today

EMERYVILLE, Calif., July 27, 2020 /PRNewswire/ -- Amyris, Inc.

Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application

Trulieve Cannabis Corp.

Turning Point Brands

Smaller and speculative marijuana stocks took a beating following the initial coronavirus strike. However, they could also generate massive profitability for the risk-tolerant speculator.

9 Smaller Marijuana Stocks You Shouldn’t Ignore

LOS ANGELES--(BUSINESS WIRE)---- $AMRS #AMRS--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $AMRS #AMRS--INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims Against Amyris, Inc.

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm

BIO-key Int.

Cocrystal Pharma

Everspin Technologies

Old Second Bancorp

Markets are down today, pretty much from the get-go. As investors become increasingly concerned with the worsening coronavirus cases, it's become clear that a sell-off is imminent.

Short Positions To Take Amid Stock Market’s Sharp Decline

Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.

Implied Volatility Surging for Amyris (AMRS) Stock Options

Aphria

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

These are the marijuana stocks with the best value, fastest growth, and most momentum for July.

Top Marijuana Stocks for July 2020

Cara Therapeutics

Cronos Group

Tilray Brands

These marijuana stocks on the Nasdaq are top for value, growth, and performance for July 2020.

Top Marijuana Stocks on the NASDAQ for July 2020

Agenus

Inspired Entertainment

OpGen

RTI Surgical

If you’re looking for some hedges for your portfolio or are looking to shift against the market, our deep learning algorithms and AI technology have several Top Shorts for you today.

Top Stocks To Short During Current Market Sell Off

Sugary taste with zero calories sounds delicious to investors.

Why Amyris Stock Popped 12.5% on Monday

EMERYVILLE, Calif., June 4, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has successfully...

Amyris Raises $200 Million From Private Placement

Coty

Stock Market Wrap-Up: Why These 2 Under-the-Radar Stocks Jumped Monday

A bullish article is pushing shares higher, but investors need to remain grounded.

Here's Why Amyris Is Soaring Today

A more effective way of delivering CBD could unlock significant growth opportunities for this unknown small-cap.

This Could Be the Next Big Pot Stock

Why Amyris Could Be The Next Tesla

EMERYVILLE, Calif., May 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of "Baby Cream to...

Amyris Launches Safe Alternative To Talc-Based Baby Powder

Investors are less than two years removed from a significant accounting discrepancy. A closer look at SEC filings reveals another potential cause for concern.

Is Another Accounting Issue Brewing for Amyris?

Investors were pleased by relatively positive operating results in the first quarter of 2020. Can the synthetic biology company turn those results into a durable trend?

News for Amyris Stock (AMRS)